DNMT1基因多态性对胃癌患者术后生存时间的影响

doi:10.13481/j.1671-587x.20150426

吉林大学学报(医学版) ›› 2015, Vol. 41 ›› Issue (04): 802-807.doi: 10.13481/j.1671-587x.20150426

DNMT1基因多态性对胃癌患者术后生存时间的影响

武兴¹, 贾志芳¹, 尤丽丽¹, 曹东慧¹, 王川¹, 曹雪源², 姜晶¹

1. 吉林大学第一医院临床流行病学研究中心, 吉林长春 130021;
2. 吉林大学第一医院胃结直肠外科, 吉林长春 130021

收稿日期:2015-02-28 发布日期:2015-08-01
通讯作者: 曹雪源,副教授,硕士研究生导师(Tel:0431-81875609,E-mail:caoxy@aliyun.com.cn);姜晶,副教授,硕士研究生导师(Tel:0431-81875408,E-mail:jiangjing19702000@jlu.edu.cn) E-mail:caoxy@aliyun.com.cnjiangjing19702000@jlu.edu.cn
作者简介:武兴(1989-),女,吉林省长春市人,在读医学硕士,主要从事胃肠道肿瘤分子流行病学方面的研究。
基金资助:
国家自然科学基金资助课题(81072369,81273065,81373084);吉林大学白求恩B项目资助课题(2012027);吉林大学第一医院青年基金资助课题(JDYY42013014)

Influence of single nucleotide polymorphisms of DNMT1 gene in survival of patients with gastric cancer after operation

WU Xing¹, JIA Zhifang¹, YOU Lili¹, CAO Donghui¹, WANG Chuan¹, CAO Xueyuan², JIANG Jing¹

1. Research Center of Clinical Epidemiology, First Hospital, Jilin University, Changchun 130021, China;
2. Department of Gastric and Colorectal Surgery, First Hospital, Jilin University, Changchun 130021, China

Received:2015-02-28 Published:2015-08-01

摘要/Abstract

摘要：

目的: 探讨中国北方汉族人群DNA甲基转移酶1(DNMT1)基因单核苷酸多态性(SNPs)与胃癌患者术后生存时间的关系,阐明DNMT1基因多态性与胃癌预后的关联性。方法: 选取447例经胃癌根治术治疗的胃癌患者纳入研究队列。利用TaqMan SNP技术检测DNMT1的5个SNPs位点(rs16999593、rs10420321、rs2288349、rs2228611和rs2228612)的基因型分布。对447例胃癌术后患者进行长期跟踪随访,采用Kaplan-Meier方法计算胃癌患者术后的生存时间并绘制生存曲线;以Log-rank检验分析不同基因型患者生存时间的差异。利用单因素和多因素Cox回归模型计算风险比(HR)及95%可信区间(CI)。结果: 与DNMT1基因rs2228611 GG基因型比较,携带GA/AA基因型的患者预后更好,生存时间更长(52.5和42.9个月,Log-rank P=0.006)。在多因素回归调整了混杂因素后,与rs2228611 GG基因型比较,携带GA/AA基因型患者的死亡风险下降了32%(HR:0.68,95% CI:0.50~0.92,P=0.013),表明rs2228611 位点基因多态是胃癌患者术后生存的独立影响因素。未发现其余4个位点的基因多态性与胃癌患者预后有关联性。结论: 中国北方汉族人群DNMT1 rs2228611 GA/AA基因多态性胃癌患者的生存时间延长,DNMT1基因多态性可作为预测胃癌预后的分子标志。

关键词: DNA甲基转移酶1, 胃肿瘤, 单核苷酸多态性, 预后

Abstract:

Objective To investigate the association between the single nucleotide polymorphisms(SNPs)of DNA methyltransferase 1(DNMT1) gene and the survival of the patients with gastric cancer after operation in the Han population from North China,and to clarify the association between the polymorphisms of DNMT1 gene and prognosis of gastric cancer. Methods A total of 447 gastric cancer patients treated with total gastrectomy were selected into the cohort study.The distribution of genotypic frequencies of five SNPs sites(rs16999593,rs10420321,rs2288349,rs2228611 and rs2228612)of DNMT1 were detected by TaqMan assay.447 cases of gastric cancer patients were followed up.Kaplan-Meier method was used to calculate the survival and draw the survival curves,and Log-rank test was used to compare the differences of overall survival(OS)between the patients with different genotypes.The hazardratio (HR)and 95% confidence interval(CI)were estimated by univariate and multivariate Cox regression analysis. Results Compared with the patients carried GG genotype at the rs2228611 site,the patients with GA/AA genotypes had better prognosis and Longer survival time(52.5 months vs 42.9 months,Log-rank P=0.006).After adjusting the confounding factors,the patients carried rs2228611 GA/AA genotypes had a decreased death risk than the patients with GG genotype(HR 0.68,95% CI:0.50-0.92,P=0.013),suggesting that the polymorphisms of rs2228611 site was an independent influencing factor of prognosis of the patients with gastric cancer after operation. There was no association between the polymorphisms of other sites and the prognosis of gastric cancer. Conclusion The polymorphisms of DNMT1 rs2228611 GA/AA genotypes can prolong the survival time of the patients with gastric cancer.The polymorphism of DNMT1 could be used as a biomarker to predict the prognosis of gastric cancer.

Key words: DNA methyltransferase1, stomach neoplasms, single nucleotide polymorphisms, prognosis

中图分类号:

R735.2

武兴, 贾志芳, 尤丽丽, 曹东慧, 王川, 曹雪源, 姜晶. DNMT1基因多态性对胃癌患者术后生存时间的影响[J]. 吉林大学学报(医学版), 2015, 41(04): 802-807.

WU Xing, JIA Zhifang, YOU Lili, CAO Donghui, WANG Chuan, CAO Xueyuan, JIANG Jing. Influence of single nucleotide polymorphisms of DNMT1 gene in survival of patients with gastric cancer after operation[J]. Journal of Jilin University Medicine Edition, 2015, 41(04): 802-807.

参考文献

[1] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-386.

[2] Snaith A,El-Omar EM.Helicobacter pylori:host genetics and disease outcomes[J].Expert Rev Gastroenterol Hepatol,2008,2(4):577-585.

[3] Zhou J,Liu ZY,Li CB,et al.Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer[J].Tumour Biol,2014,36(4):3017-3023.

[4] Ksiaa F,Ziadi S,Dhiab MB,et al.Increased DNA methyltransferase 1 protein expression correlates significantly with intestinal histological type and gender in gastric carcinomas[J].Adv Med Sci,2014,60(1):50-57.

[5] Shi J F,Li XJ,Si XX,et al.ERalpha positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells[J].Biochem Biophys Res Commun,2012,427(1):47-53.

[6] Sun MY,Yang XX,Xu WW,et al.Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China[J].Genet Mol Res,2012, 11(4):4330-4341.

[7] Mostowska A,Sajdak S,Pawlik P,et al.DNMT1,DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population[J].Mol Biol Rep,2013,40(8):4893-4899.

[8] De La Vega FM.Selecting single-nucleotide polymorphisms for association studies with SNP browser software[J].Methods Mol Biol,2007,376:177-193.

[9] Jeltsch A.Molecular enzymology of mammalian DNA methyltransferases[J].Curr Top Microbiol Immunol,2006,301:203-225.

[10] Subramaniam D,Thombre R,Dhar A,et al.DNA methyltransferases:a novel target for prevention and therapy[J].Front Oncol,2014,4:80.

[11] Dhe-Paganon S,Syeda F,Park L.DNA methyl transferase 1:regulatory mechanisms and implications in health and disease [J].Int J Biochem Mol Biol,2011,2(1):58-66.

[12] Singh V,Sharma P,Capalash N.DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer [J].Curr Cancer Drug Targets,2013,13(4):379-399.

[13] Tang H,Deng M,Tang Y,et al.miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression [J].Clini Cancer Res,2013,19(20):5602-5612.

[14] Xu Z,Taylor JA.SNPinfo:integrating GWAS and candidate gene information intofunctional SNP selection for genetic association studies[J].Nucleic Acids Res,2009,37(Web Server issue):W600-605.

[15] Lee PH, Shatkay H.F-SNP:computationally predicted functional SNPs for disease association studies[J].Nucleic Acids Res,2008,36(suppl 1):D820-D824.

[16] Mostowska A,Sajdak S,Pawlik P,et al.DNMT1,DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population [J].Mol Biol Rep,2013,40(8):4893-4899.

[17] Ye C,Beeghly-Fadiel A,Lu W,et al.Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk[J].Breast Cancer Res Treat,2010,121(3):765-769.

[18] Jiang J,Jia Z,Cao D,et al.Polymorphisms of the DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy[J].PLoS One,2012,7(9):e46058.

[19] 孙婷,李平,张梅.晚期胃癌维持治疗现状[J].吉林中医药,2014,34(10):1077-1080.

DNMT1基因多态性对胃癌患者术后生存时间的影响

Influence of single nucleotide polymorphisms of DNMT1 gene in survival of patients with gastric cancer after operation

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	赵丹, 曹东慧, 金美善, 吴孟辉, 王玥琦, 杨娜, 周天宇, 张厚君, 姜晶, 曹雪源. β-甘草次酸对炎症相关胃癌的抑制作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(06): 1150-1155.
[2]	马立聪, 高芳, 董文杰, 田旭阳, 党彤, 贾彦彬. ITGA1基因多态性与幽门螺杆菌感染的关联性分析[J]. 吉林大学学报(医学版), 2018, 44(06): 1275-1279.
[3]	朱广伟, 郑炜, 黄永建, 华进, 杨树钢, 叶建新. 髓样分化因子88在结直肠癌患者癌组织中的表达及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(05): 1047-1051.
[4]	朱涛, 张国明, 严飞, 刘正, 霍强. 急性心肌梗死患者PCI术后心率变异性对主要不良心脏事件的评估价值[J]. 吉林大学学报(医学版), 2018, 44(04): 780-785.
[5]	邢少姬, 郑连生, 王殿栋, 张萱, 池敏. 硒蛋白S基因单核苷酸多态性与肝癌发病风险的关联性分析[J]. 吉林大学学报(医学版), 2018, 44(03): 558-562.
[6]	高欢, 白元松, 代恩勇, 韩冷, 卢振霞, 赵亚男. 复发/难治性儿童B淋巴母细胞淋巴瘤1例报告及文献复习[J]. 吉林大学学报(医学版), 2018, 44(02): 416-420.
[7]	于云鹤, 杜烨, 韩冰, 李嗣杰, 宋乐连, 范志民. 新辅助化疗对Luminal B型乳腺癌各亚组的疗效观察及预后分析[J]. 吉林大学学报(医学版), 2018, 44(02): 356-362.
[8]	范励雯, 付彤, 古林, 吴迪, 贾泓瑶, 宋东. 副乳腺癌1例报告及文献复习[J]. 吉林大学学报(医学版), 2018, 44(02): 412-415.
[9]	何欣, 杨婷婷, 高阳阳, 宋艳秋. 乳腺癌患者心理韧性及其心理干预方式的研究进展[J]. 吉林大学学报(医学版), 2018, 44(02): 455-460.
[10]	杨冬野, 焦洋, 檀碧波, 杜志坚, 胡晓杰, 刘飞. Gli1基因在胃癌组织中的表达及其对胃癌细胞生物学特性的影响[J]. 吉林大学学报(医学版), 2018, 44(01): 63-67.
[11]	刘刚, 赵民学, 王德盛. 血清胃蛋白酶原、胃泌素17和幽门螺杆菌抗体检测在胃癌筛查中的应用[J]. 吉林大学学报(医学版), 2017, 43(06): 1182-1185.
[12]	孙慧颖, 杜波, 禹智, 刘洪泉, 于红. 突发性聋伴良性阵发性位置性眩晕病例分析并文献复习[J]. 吉林大学学报(医学版), 2017, 43(05): 1025-1029.
[13]	文思敏, 于多, 吕欣, 王铁君. 紫杉醇联合顺铂与单药顺铂2种同步放化疗方案对中晚期宫颈癌患者预后的影响及安全性评价[J]. 吉林大学学报(医学版), 2017, 43(05): 1002-1008.
[14]	苏军燕, 李迎今, 徐长妍. 急性白血病患儿白血病干细胞表面CD96和CD71的表达对其疗效和预后的影响[J]. 吉林大学学报(医学版), 2017, 43(04): 776-781.
[15]	杨冬阳, 赖晓嵘, 黎莹, 马立宇, 罗刚, 李子俊, 徐飞, 马冬. Ⅳ期结直肠癌轻微症状患者原发灶切除和KRAS基因突变对其预后的影响[J]. 吉林大学学报(医学版), 2017, 43(04): 805-811.